Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWA Combined With Chemotherapy for Colorectal Liver Metastases
NCT04562727Not yet recruiting
- Start
- Mar 2021
- Primary completion
- Aug 2022
01
Overview
Open-label trial in colorectal liver metastases (CRLM) (3 arms). Primary endpoint: Disease Free Survival at 60 months. Planned start Mar 2021; status: not yet recruiting.
02
Conditions
colorectal liver metastases (CRLM)
Beyond the preview
Go deeper on NCT04562727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04562727.